ABOS Acumen Pharmaceuticals - ebd bispecific antibodies show improved brain penetration compared to native anti-aβo antibodies - No hematolo

ABOS Acumen Pharmaceuticals - ebd bispecific antibodies show improved brain penetration compared to native anti-aβo antibodies - No hematological safety signals observed for acu401 in non-human primates